Evidence map›Paper›PMID 41918702›Full record

ReviewFrontiers in bioengineering and biotechnology2026

Beyond traditional models: microfluidic technologies for engineering the human placenta

Alice Masserdotti, Anna Cargnoni, Rashmi Ramakrishnan, Lisa Muiznieks, Justine Lereculey-Beaumanoir, Ivana Brenta, Michael Gasik, Paola Chiodelli, Antonietta Rosa Silini, Ornella Parolini

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alice MasserdottiDepartment of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Anna CargnoniCentro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Rashmi RamakrishnanCURAM Research Ireland Centre for Medical Devices, University of Galway, Galway, Ireland.
Lisa MuiznieksMicrofluidics Innovation Center, Paris, France.
Justine Lereculey-BeaumanoirMicrofluidics Innovation Center, Paris, France.
Ivana BrentaMicrofluidics Innovation Center, Paris, France.
Michael GasikSeqvera Ltd., Helsinki, Finland.
Paola ChiodelliDepartment of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Antonietta Rosa SiliniCentro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
Ornella ParoliniDepartment of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human placenta is a highly specialized and dynamic organ that supports fetal development by regulating maternal-fetal exchange, endocrine activity, and immune tolerance throughout pregnancy. Despite its central role in maternal and fetal health, studying human placental physiology and pathology remains challenging due to ethical constraints, limited tissue accessibility, and the complexity of the maternal-fetal interface. Traditional

Indexed as

microfluidicsmodelingplacentaplacental modelsplacenta-on-chip

Identifiers

PMID41918702
PMCPMC13033721

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.